Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

US FDA awards orphan drug designation to Minoryx’s MIN-102 compound

pharmaceutical-technologyFebruary 27, 2017

Tag: FDA , Orphan Drug

PharmaSources Customer Service